While these medications offer profound weight loss results, they have created a new clinical challenge known as "Ozempic Body" or "Ozempic Face", characterized by significant skin laxity and muscle loss due to rapid weight reduction
It is important to monitor for any potential side effects and discuss with your healthcare provider regularly
Professors Wassilios Meissner and Olivier Rascol of Toulouse University Hospital, who led the trial, said the findings constitute a significant step forward in the future management of the disease, adding that they "look forward to confirming these encouraging results in the future in order to translate such findings into clinical practice. According to neurology specialist Professor Tom Foltynie of University College London who was not involved in the study the new study is an important publication that replicates the findings of an earlier study in Parkinsons of a similar GLP-1 agonist, exenatide, which was published in The Lancet in 2017
Cell Signal 20 (10), 17151724
Where DPC tends to be enough: You want faster access to a doctor when something feels off You need help starting or adjusting medication You want regular check-ins without worrying about copays You are trying to figure out whether therapy is needed Where it usually falls short: You already know you need weekly therapy You are dealing with trauma, grief, or long-term counseling needs You need specialist psychiatry You want structured mental health treatment beyond primary care If you are looking at options right now, it helps to look at how those pieces fit together before making a switch
